Hexa Reports Nicotine Addiction Therapeutics Market Pipeline Re

Nicotine Addiction Therapeutics Market Pipeline Review, H2
2017
“Pharmaceutical and Healthcare disease pipeline guide Nicotine Addiction -
Pipeline Review, H2 2017, provides an overview of the Nicotine Addiction
(Central Nervous System) pipeline landscape.”
Summary
Pharmaceutical and Healthcare disease pipeline guide Nicotine Addiction - Pipeline Review, H2 2017,
provides an overview of the Nicotine Addiction (Central Nervous System) pipeline landscape.
Nicotine addiction also called tobacco dependence is an addiction to tobacco products caused by the drug
nicotine. Predisposing factors include age, depression, schizophrenia, post-traumatic stress disorder and
alcoholism. Person experiences withdrawal symptoms at cessation of using, such as shaky hands, sweating,
irritability, or rapid heart rate. Treatment includes nicotine replacement therapy (NRT).
Report Highlights
Pharmaceutical and Healthcare latest pipeline guide Nicotine Addiction - Pipeline Review, H2 2017, provides
comprehensive information on the therapeutics under development for Nicotine Addiction (Central Nervous
System), complete with analysis by stage of development, drug target, mechanism of action (MoA), route of
administration (RoA) and molecule type. The guide covers the descriptive pharmacological action of the
therapeutics, its complete research and development history and latest news and press releases.
Browse Detail Report With TOC @
https://www.hexareports.com/report/nicotine-addiction-pipeline-review-h2-2017
Follow Us: